PTHS · Company research

Pelthos Therapeutics Inc. (PTHS): Stock News & Events

Recent company-linked news records available in the database.

RESEARCH CONTEXT

Understand the numbers

Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.

17records availableHealthcare

Stock News & Events data

Database-backed records only

17 rows
titlesummaryurlsourcepublished atsentimentsentiment scorerelevance score
Pelthos Therapeutics Inc. (PTHS) - What Are Analysts Saying About This Stock? - MarketBeatPelthos Therapeutics Inc. (PTHS) - What Are Analysts Saying About This Stock? MarketBeatView source ↗MarketBeatOct 18, 2026neutral00.6
Pelthos Therapeutics (PTHS) Stock Fair Value Falls After Analysts Cut Zelsuvmi Launch Estimates - Yahoo FinancePelthos Therapeutics (PTHS) Stock Fair Value Falls After Analysts Cut Zelsuvmi Launch Estimates Yahoo FinanceView source ↗Yahoo FinanceOct 14, 2026neutral00.6
Pelthos Therapeutics (NYSEAMERICAN:PTHS) Stock Rating Lowered by Zacks Research - MarketBeatPelthos Therapeutics (NYSEAMERICAN:PTHS) Stock Rating Lowered by Zacks Research MarketBeatView source ↗MarketBeatOct 9, 2026neutral00.6
Pelthos Therapeutics (NYSEAMERICAN:PTHS) Stock: Insider Peter Greenleaf Sells 797 Shares - MarketBeatPelthos Therapeutics (NYSEAMERICAN:PTHS) Stock: Insider Peter Greenleaf Sells 797 Shares MarketBeatView source ↗MarketBeatOct 6, 2026neutral00.6
Pelthos Therapeutics (NYSEAMERICAN:PTHS) Director Sells 558 Shares of Stock - MarketBeatPelthos Therapeutics (NYSEAMERICAN:PTHS) Director Sells 558 Shares of Stock MarketBeatView source ↗MarketBeatOct 6, 2026neutral00.6
Under a trading plan, Pelthos Therapeutics (PTHS) director sells 797 shares at $21.17. - Stock TitanUnder a trading plan, Pelthos Therapeutics (PTHS) director sells 797 shares at $21.17. Stock TitanView source ↗Stock TitanOct 6, 2026neutral00.6
For estimated vesting taxes, a Pelthos Therapeutics (PTHS) director sold 786 shares at $21. - Stock TitanFor estimated vesting taxes, a Pelthos Therapeutics (PTHS) director sold 786 shares at $21. Stock TitanView source ↗Stock TitanOct 6, 2026neutral00.6
Pelthos Therapeutics (PTHS) Rises 4.78% to $21.48, Pressing Against Upper Resistance - Sector ETF Flow - https://www.siam.in/Pelthos Therapeutics (PTHS) Rises 4.78% to $21.48, Pressing Against Upper Resistance - Sector ETF Flow https://www.siam.in/View source ↗https://www.siam.in/Oct 6, 2026neutral00.6
Pelthos Therapeutics Inc (PTHS-A) Stock Price and News - The Globe and MailPelthos Therapeutics Inc (PTHS-A) Stock Price and News The Globe and MailView source ↗The Globe and MailOct 1, 2026neutral00.6
Stockholders elect eight directors as Pelthos Therapeutics (PTHS) adopts its 2026 stock incentive plan. - Stock TitanStockholders elect eight directors as Pelthos Therapeutics (PTHS) adopts its 2026 stock incentive plan. Stock TitanView source ↗Stock TitanOct 1, 2026neutral00.6
Pelthos Therapeutics (PTHS) Holds Midpoint of Trading Band at $22.34 - Leveraged ETF Flow - https://www.dars.gov.et/Pelthos Therapeutics (PTHS) Holds Midpoint of Trading Band at $22.34 - Leveraged ETF Flow https://www.dars.gov.et/View source ↗https://www.dars.gov.et/Sep 28, 2026neutral00.6
Pelthos Therapeutics (PTHS) Holds Midpoint of Trading Band at $22.34 - Institutional Flow Picks - https://www.dars.gov.et/Pelthos Therapeutics (PTHS) Holds Midpoint of Trading Band at $22.34 - Institutional Flow Picks https://www.dars.gov.et/View source ↗https://www.dars.gov.et/Sep 28, 2026neutral00.6
Pelthos Therapeutics Inc. (PTHS) Q2 2026 Earnings: Deep EPS Miss Sends Shares Lower - Revenue Guidance Range - dars.gov.etPelthos Therapeutics Inc. (PTHS) Q2 2026 Earnings: Deep EPS Miss Sends Shares Lower - Revenue Guidance Range dars.gov.etView source ↗dars.gov.etSep 9, 2026neutral00.6
$PTHS ($PTHS) Releases Q2 2026 Earnings - Quiver Quantitative$PTHS ($PTHS) Releases Q2 2026 Earnings Quiver QuantitativeView source ↗Quiver QuantitativeAug 13, 2026neutral00.6
Pelthos Therapeutics Inc. (PTHS) Reports Q2 Loss, Lags Revenue Estimates - Yahoo FinancePelthos Therapeutics Inc. (PTHS) Reports Q2 Loss, Lags Revenue Estimates Yahoo FinanceView source ↗Yahoo FinanceAug 13, 2026neutral00.6
PTHS Forecast — Price Target — Prediction for 2027 - TradingViewPTHS Forecast — Price Target — Prediction for 2027 TradingViewView source ↗TradingViewJun 25, 2026neutral00.6
symbol__ Stock Quote Price and Forecast - CNNsymbol__ Stock Quote Price and Forecast CNNView source ↗CNNJul 4, 2025neutral00.6

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.